Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Clinical trial NCT03644589 · WITHDRAWN

Trial details

NCT number: NCT03644589
Sponsor: University of Washington
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor Negative HER2/Neu Negative Metastatic Breast Cancer Progesterone Receptor Negative Recurrent Breast Carcinoma Triple Negative Breast Cancer

Start date: 2019-04-01
Primary completion: 2021-10-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.